HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors

International Journal of Molecular Sciences
Eckhard KlieserDaniel Neureiter

Abstract

Epigenetic factors are essentially involved in carcinogenesis, tumor promotion, and chemoresistance. Two epigenetic key players are miRNAs and histone deacetylases (HDACs). As previously shown by own theoretical databank analysis, the crosstalk between miRNAs and HDACs is relevant in different human chronic diseases and cancerogenic pathways. We aimed to investigate a potential connection between the expression of a well-defined subset of "proliferation-associated" miRNAs and the expression of HDACs as well as clinical parameters in pancreatic neuroendocrine tumors (pNETs). Expression levels of miRNA132-3p, miRNA145-5p, miRNA183-5p, miRNA34a-5p, and miRNA449a in 57 pNETs resected between 1997 and 2015 were measured and linked to the immunohistochemical expression pattern of members of the four HDAC classes on human tissue microarrays. All pNET cases were clinically and pathologically characterized according to published guidelines. Correlation analysis revealed a significant association between expression of specific miRNAs and two members of the HDAC family (HDAC3 and HDAC4). Additionally, a linkage between miRNA expression and clinico-pathological parameters like grading, TNM-staging, and hormone activity was found. Moreover,...Continue Reading

References

Jun 24, 2004·Nature Reviews. Genetics·Lin He, Gregory J Hannon
Jul 28, 2007·Current Biology : CB·Guido T BommerEric R Fearon
Jan 6, 2009·World Journal of Surgery·Linda YangDavid H Berger
Jun 1, 2007·Molecular Oncology·Santiago Ropero, Manel Esteller
May 5, 2009·The Oncologist·Florian EhehaltRobert Grützmann
Sep 19, 2009·Nature Reviews. Genetics·Carlo M Croce
Jan 29, 2011·Langenbeck's Archives of Surgery·Simon SchimmackIrvin M Modlin
Feb 26, 2011·Endocrinology and Metabolism Clinics of North America·Ben LawrenceIrvin M Modlin
Mar 23, 2011·Molecular Cancer·Tony Bou KheirLennart Friis-Hansen
Nov 15, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hyo Sung JeonJi Woong Son
Nov 30, 2011·Endocrine·Krystallenia I Alexandraki, Gregory Kaltsas
Feb 9, 2012·Oncogene·A FormosaE Candi
May 23, 2012·International Journal of Oncology·Ralf KemmerlingTobias Kiesslich
Feb 27, 2013·Neoplasia : an International Journal for Oncology Research·Kai DobersteinPaul Gutwein
Jun 8, 2013·ILAR Journal·Shama ViraniLaura S Rozek
Jun 27, 2013·Molecular and Cellular Biochemistry·Jie YangShiping Fu
Jan 5, 2014·Cold Spring Harbor Perspectives in Biology·Gary Felsenfeld
Feb 15, 2014·Oncology Letters·Ralf KemmerlingDaniel Neureiter
Nov 26, 2014·Methods in Molecular Biology·Rajnee KanwalSanjay Gupta
Mar 15, 2015·Expert Opinion on Biological Therapy·Stefan SwierczynskiDaniel Neureiter
Dec 23, 2015·World Journal of Gastrointestinal Oncology·Eckhard KlieserRomana Illig
Mar 5, 2016·Oncotarget·Wei ShiFei-Fei Liu
Dec 14, 2016·BioMed Research International·Christian MayrTobias Kiesslich
Oct 5, 2017·Future Oncology·Veronika HolubekovaZora Lasabova
Oct 13, 2017·Anti-cancer Drugs·He Yong-MingChen Ye
Jan 20, 2018·BioMed Research International·Krystallenia I AlexandrakiGregory A Kaltsas
Mar 28, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Cheng-Liang YangQing-Xia Fan
Apr 24, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Feng LiLu Bai

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques

Software Mentioned

SPSS

Related Concepts

Related Feeds

Carcinoma, Islet Cell

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arises in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Carcinoma here.

Carcinoma, Islet Cell (Keystone)

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arise in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on islet cell carcinoma in this feed.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.